Vumerity (diroximel fumarate) approved for relapsing remitting MS in Scotland
7 February 2022
Vumerity (diroximel fumarate) has been approved by the Scottish Medicines Consortium for people with relapsing remitting multiple sclerosis.
What is it like to have a lumbar puncture?
6 December 2021
A woman who underwent a lumbar puncture during her diagnosis for MS (multiple sclerosis) shares her personal account of the process.
Ask the expert: sex and MS
9 February 2021
Starting a conversation about sexual problems with a health professional can often feel daunting. Lesley Catterall and Denise Middleton, two MS specialists answer your questions.
Can cacao really help with MS fatigue?
24 June 2019
Cocoa, cacao and multiple sclerosis fatigue. A personal story from a person with MS who took part in a research trial testing the effect of high flavonoid cacao on MS fatigue.
Invisible symptoms and me, Martin's story
24 May 2019
In his latest blog Martin Baum discusses how raising awareness of the invisible symptoms of MS can only be a good thing.
MS in the Media - 17 May 2019
17 May 2019
- Statin has potential as SPMS drug
- EastEnders MS storyline
"When you lose something, it makes you appreciate what you have"
13 May 2019
Danielle MacGillivray talks to us about coming to terms with her MS diagnosis and learning to "appreciate the little things" every single day.
My Vespa adventure for the MS Trust
13 May 2019
For his next fundraising adventure, our supporter Nick Jolly will be riding 2,500 miles to Hungary on his Vespa scooter. He tells us about the inspiration behind his challenge.
MS in the Media - 10 May 2019
10 May 2019
- Ocrevus approved for PPMS
- Lack of services for people with advanced MS
- Fasting diet helps MS symptoms
Microaggressions at work; more than just hurt feelings
9 May 2019
In what they believe to be the first study of its kind, US researchers investigated the impact of microaggressions (subtle discriminatory actions) experienced by people with MS at work.
Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS
9 May 2019
The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS.
Living with primary progressive MS: Yvonne's story
8 May 2019
Yvonne Pettigrew, diagnosed with primary progressive MS (PPMS) in 2013, shares her experience of living with PPMS and reacts to the "exciting" news that Ocrevus has been approved by NICE for NHS treatment of early, inflammatory PPMS.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.